Literature DB >> 15850411

Relative biological effectiveness of 103Pd and 125I photons for continuous low-dose-rate irradiation of Chinese hamster cells.

Ravinder Nath1, Paul Bongiorni, Zhe Chen, Jillian Gragnano, Sara Rockwell.   

Abstract

Monolayers of Chinese hamster lung cells (CCL-16) in a polystyrene phantom were irradiated in vitro by 103Pd and 125I sources at dose rates of 6 to 72 cGy/h. Cell survival curves for acute high-dose-rate irradiation (over 30 Gy/h) were also measured using nearly monoenergetic X-ray beams which were designed to simulate the mean energies of photons emitted by 125I and 103Pd and also using a clinical 250 kVp X-ray beam. A profound dose-rate effect is observed over the dose-rate range of 6 to 20 cGy/h. An inverse dose-rate effect was observed for both radionuclides, with its onset occurring at a dose rate of about 20-30 cGy/h. The average RBE of 103Pd relative to 125I was determined to be 1.45 +/- 0.07, 1.41 +/- 0.07, 0.70 +/- 0.07 and 1.49 +/- 0.07 at dose rates of 6.9, 12.6, 19.0 and 26.7 cGy/h, respectively. Because 103Pd implants are generally prescribed at a higher initial dose rate (21 cGy/h) than the corresponding 125I implants (7 cGy/h), the effects of both dose rate and photon energy on biological response must be considered together. For the CCL-16 cells, the RBE of 103Pd at 19.0 cGy/h relative to that of 125I at 6.9 cGy/h was estimated to be 2.3 +/- 0.5.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15850411     DOI: 10.1667/rr3363

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  2 in total

1.  Average stopping powers for electron and photon sources for radiobiological modeling and microdosimetric applications.

Authors:  Oleg N Vassiliev; Stephen F Kry; David R Grosshans; Radhe Mohan
Journal:  Phys Med Biol       Date:  2018-03-02       Impact factor: 3.609

2.  The biological effect of 125I seed continuous low dose rate irradiation in CL187 cells.

Authors:  Hong-Qing Zhuang; Jun-Jie Wang; An-Yan Liao; Ji-Dong Wang; Yong Zhao
Journal:  J Exp Clin Cancer Res       Date:  2009-01-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.